A digest of college news coverage for May/June 2022

FPM dean, Associate Professor Mick Vagg, is calling on faculty fellows to condemn the Australian Government's decision to cut $40 million from desperately needed services for people living with chronic pain after it rejected key recommendations from a national taskforce.

This new resource for patients provides a summary of our position on prescribing medicinal cannabis for people with chronic non-cancer pain.

FPM has written to Australian health officials seeking an urgent response to concerns about imminent MBS changes

FPM update on the use of spinal cord stimulators in Australia.

An ANZCA Clinical Trials Network breast cancer pain relief trial has been awarded a $4.3 million grant.

The board has approved a new position statement on the use of ketamine in the management of chronic non-cancer pain

The college has provided a 2022 election priorities statement to the major political parties.

Interested in pain research? We’re inviting fellows to help us develop a proposal for a new research network.

Read a report of the FPM Board meeting held on 10 April 2022.